Levin Arthur A

Levin Arthur A is listed in filings as Director at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK) and Avidity Biosciences Inc (RNAM). The current snapshot covers public activity from Mar 20, 2025 to Jun 5, 2026. Reported amounts are shown as $524.0K to $3.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.